IHS Chemical Week

Regions :: Western Europe :: Netherlands

DSM reports lower sales, earnings on negative currency effects, weakness in caprolactam

8:14 AM MDT | August 5, 2014 | Natasha Alperowicz

DSM today reported second-quarter net profit from continuing operations before exceptional items of €110 million ($147.6 million), 20% down on the year-earlier quarter. Revenues from continuing operations were flat, €2.29 billion, and Ebitda was 12% lower, €293 million. The nutrition segment's revenues dropped 3%, to €1.07 billion, and Ebitda was 11% down, at €222 million. The performance materials business recorded sales of €702 million, 1% down on the second quarter of 2013, and a 10% rise in Ebitda, to €88 million. Polymer...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa